Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Paus, Ralf

University Of Miami School Of Medicine
United States

Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia 1R21CA277418-01A1 Rachel Altshuler, Ph.D.
Pena, Maria Marjorette

University Of South Carolina At Columbia
United States

The Role of Early Life Exposure to Antibiotics on Risk of Early Onset Colorectal Cancer 1R21CA281729-01A1
Peppone, Luke Joseph

University Of Rochester
United States

High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients 5R01CA258349-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Perkins, Susan M

Indiana University Indianapolis
United States

Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention 5R01CA235632-06 Brennan Streck, Ph.D., RN, M.P.H.
Perlis, Michael Lloyd

University Of Pennsylvania
United States

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients 1R21CA270987-01 PAR-20-292 (R21 Clinical Trial Optional) Brandy Heckman-Stoddard, Ph.D., M.P.H.
Permuth, Jennifer B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 4R37CA229810-06 Matthew Young, Ph.D.
Peters, Jeffrey M

Pennsylvania State University, The
United States

Unique targeting of PPARβ/δ regulation for cancer prevention and therapy 5R01CA239256-05 Marjorie Perloff, M.D.
Pfleger, Cathie M

Icahn School Of Medicine At Mount Sinai
United States

A Drosophila model for Aromatase Inhibitor-induced Musculoskeletal Pain 1R21CA303409-01 Rachel Altshuler, Ph.D.
Phillips, Nicholas S

St. Jude Children'S Research Hospital
United States

Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors 5R21CA280230-02 Eileen Dimond, R.N., M.S.
Pinder, Leeya F

University Of Cincinnati
United States

RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial) 5R37CA284033-02 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.